Over the past 12 months, Labcorp Holdings insiders sold $13.7 million of stock on the open market (49.19K shares) and made no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Adam H Schechter | President Ceo | 102,565 | 0 | 102,565 | 28.3% | 12 Aug, 2026 |
| 2 | Glenn A Eisenberg | Executive Vice President | 37,920 | 0 | 37,920 | 10.5% | 31 Mar, 2025 |
| 3 | Brian J Caveney | Evp, Pres Of Ed, Cmo Cso | 36,492 | 0 | 36,492 | 10.1% | 30 Mar, 2026 |
| 4 | Lance Berberian | Evp, Special Advisor, Strategy | 18,652 | 0 | 18,652 | 5.1% | 31 Mar, 2025 |
| 5 | Jean-Luc Belingard | Director | 17,781 | 0 | 17,781 | 4.9% | 08 Feb, 2024 |
| 6 | Peter M Neupert | Director | 13,784 | 0 | 13,784 | 3.8% | 13 Feb, 2026 |
| 7 | Garheng Kong | Director | 13,739 | 0 | 13,739 | 3.8% | 13 Feb, 2026 |
| 8 | Paul R Kirchgraber | Ceo, Covance Drug Development | 12,946 | 0 | 12,946 | 3.6% | 23 May, 2023 |
| 9 | Mark S Schroeder | Evp, Pres Diagnostics Coo | 12,677 | 0 | 12,677 | 3.5% | 30 Mar, 2026 |
| 10 | R Sanders Williams | Director | 8,120 | 0 | 8,120 | 2.2% | 08 Feb, 2024 |
| 11 | Amy B. Summy | Evp, Chief Marketing Officer | 6,956 | 0 | 6,956 | 1.9% | 06 Aug, 2026 |
| 12 | Bryan T Vaughn | Evp And President, Diagnostics | 6,746 | 0 | 6,746 | 1.9% | 06 Jul, 2026 |
| 13 | Dwight Gary Gilliland | Director | 6,656 | 0 | 6,656 | 1.8% | 01 Aug, 2025 |
| 14 | Kerrii B Anderson | Director | 6,563 | 0 | 6,563 | 1.8% | 18 Aug, 2026 |
| 15 | Der Vaart Sandra D Van | Evp, Corporate Affairs | 6,239 | 0 | 6,239 | 1.7% | 30 Mar, 2026 |
| 16 | Jonathan P. Divincenzo | Evp, Pres, Central Labs Intl | 5,461 | 0 | 5,461 | 1.5% | 29 Mar, 2024 |
| 17 | Jeffrey A. Davis | Director | 5,460 | 0 | 5,460 | 1.5% | 13 Feb, 2026 |
| 18 | Anita Z Graham | Evp, Chro | 5,185 | 0 | 5,185 | 1.4% | 30 Mar, 2026 |
| 19 | Akinbolade Oyegunwa | Evp, Cio Cto | 5,064 | 0 | 5,064 | 1.4% | 30 Mar, 2026 |
| 20 | Megan D. Bailey | Evp, Pres, Central Labs Intl | 4,851 | 0 | 4,851 | 1.3% | 30 Mar, 2026 |
| 21 | Judith C Seltz | Evp, Chro | 4,182 | 0 | 4,182 | 1.2% | 03 Apr, 2023 |
| 22 | Kathryn E Wengel | Director | 4,133 | 0 | 4,133 | 1.1% | 13 Feb, 2026 |
| 23 | Kathryn W Kyle | Evp, Chief Legal Officer | 3,904 | 0 | 3,904 | 1.1% | 06 Jul, 2026 |
| 24 | Jonathan C Meltzer | Evp, Operations | 3,620 | 0 | 3,620 | 1.0% | 30 Mar, 2026 |
| 25 | Richelle P Parham | Director | 3,366 | 0 | 3,366 | 0.9% | 13 Feb, 2026 |
| 26 | Kirsten Marie Kliphouse | Director | 3,160 | 0 | 3,160 | 0.9% | 13 Feb, 2026 |
| 27 | Paul Rothman | Director | 2,571 | 0 | 2,571 | 0.7% | 13 Feb, 2026 |
| 28 | Julia Aijun Wang | Chief Financial Officer, Evp | 1,817 | 0 | 1,817 | 0.5% | 13 Feb, 2026 |
| 29 | Peter J Wilkinson | Svp, Chief Accounting Officer | 1,770 | 0 | 1,770 | 0.5% | 05 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Sep, 2026 | Bryan T Vaughn | Evp And President, Diagnostics | Acquired A | 1,500 | $0.00 | $0 | 5,204 | Direct |
| 01 Sep, 2026 | Jonathan C Meltzer | Evp, Coo | Acquired A | 900 | $0.00 | $0 | 3,594 | Direct |
| 01 Sep, 2026 | Brian J Caveney | Evp, Pres Of Bls, Cmo Cso | Acquired A | 3,000 | $0.00 | $0 | 7,170 | Direct |
| 01 Sep, 2026 | Akinbolade Oyegunwa | Evp, Cio Cto | Acquired A | 750 | $0.00 | $0 | 2,940 | Direct |
| 17 Aug, 2026 | Kerrii B Anderson | Director | Disposed S | 3,000 | $318.02 | $954.06K | 6,563 | Direct |
| 11 Aug, 2026 | Adam H Schechter | President Ceo | Disposed S | 4,669 | $320.37 | $1.50Mn | 102,565 | Direct |
| 04 Aug, 2026 | Amy B. Summy | Evp, Chief Marketing Officer | Disposed S | 924 | $306.74 | $283.43K | 6,956 | Direct |
| 03 Aug, 2026 | Peter J Wilkinson | Svp, Chief Accounting Officer | Disposed S | 82 | $309.22 | $25.36K | 1,770 | Direct |
| 03 Aug, 2026 | Peter J Wilkinson | Svp, Chief Accounting Officer | Acquired M | 1,338 | $209.25 | $279.98K | 3,108 | Direct |
| 03 Aug, 2026 | Peter J Wilkinson | Svp, Chief Accounting Officer | Disposed S | 1,338 | $309.23 | $413.75K | 1,770 | Direct |
| 03 Aug, 2026 | Peter J Wilkinson | Svp, Chief Accounting Officer | Disposed M | 1,338 | $0.00 | $0 | 0 | Direct |
| 01 Jul, 2026 | Bryan T Vaughn | Evp And President, Diagnostics | Acquired M | 327 | — | — | 7,073 | Direct |
| 01 Jul, 2026 | Kathryn W Kyle | Evp, Chief Legal Officer | Acquired M | 256 | — | — | 4,069 | Direct |
| 01 Jul, 2026 | Kathryn W Kyle | Evp, Chief Legal Officer | Disposed F | 73 | $283.88 | $20.72K | 3,996 | Direct |
| 01 Jul, 2026 | Bryan T Vaughn | Evp And President, Diagnostics | Disposed F | 93 | $283.88 | $26.40K | 6,980 | Direct |
| 02 Jul, 2026 | Kathryn W Kyle | Evp, Chief Legal Officer | Disposed S | 92 | $286.19 | $26.33K | 3,904 | Direct |
| 02 Jul, 2026 | Bryan T Vaughn | Evp And President, Diagnostics | Disposed S | 234 | $286.19 | $66.97K | 6,746 | Direct |
| 01 Jul, 2026 | Kathryn W Kyle | Evp, Chief Legal Officer | Disposed M | 256 | $0.00 | $0 | 2,008 | Direct |
| 01 Jul, 2026 | Bryan T Vaughn | Evp And President, Diagnostics | Disposed M | 327 | $0.00 | $0 | 3,704 | Direct |
| 08 Jun, 2026 | Kathryn W Kyle | Evp, Chief Legal Officer | Disposed S | 762 | $263.89 | $201.08K | 3,813 | Direct |